Today's Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAL American Airlines Group	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Goldie Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.58 -2.1%	$19.00 ➝ $15.50	Market Perform
ABSI Absci	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vamil Divan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.55 -2.0%		Buy
ACAD ACADIA Pharmaceuticals	Target Set by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.17 -2.5%	$33.00
ACET Adicet Bio	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.54 -27.5%	$27.00 ➝ $34.00	Buy
ACHC Acadia Healthcare	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Cooper Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.85 -0.9%	$39.00	Strong-Buy ➝ Outperform
ACN Accenture	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Friedman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$174.77 -0.8%	$140.00 ➝ $153.00	Neutral
ADIG ADI Global Distribution Inc. Common Stock	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.42 -5.8%	$23.00	Inline
ADSK Autodesk	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.74 -1.3%	$338.00 ➝ $300.00	Overweight
ADUS Addus HomeCare	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Cooper Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.77 -0.4%	$137.00
AEIS Advanced Energy Industries	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Elizabeth Sun Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$275.93 -1.3%		Buy
Here’s the stock symbol I’ve promised (Ad) Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. Get the stock name and ticker symbol free of charge today
AESI Atlas Energy Solutions	Upgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eddie Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.18 -2.4%	$10.00 ➝ $14.00	Underweight ➝ Equal Weight
AGEN Agenus	Initiated by	Rodman & Renshaw Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael King Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.59 +12.2%	$19.00	Buy
AIR AAR	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Herbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$116.16 +0.0%	$145.00	Outperform
AKAM Akamai Technologies	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rudy Kessinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$110.55 -3.0%	$185.00 ➝ $150.00	Buy
AKZOY Akzo Nobel	Upgraded by	Oddo Bhf Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.60 -0.6%		Neutral ➝ Outperform
ALK Alaska Air Group	Target Set by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Goldie Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.03 -2.2%	$62.50 ➝ $50.00	Outperform
ALL Allstate	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Newsome Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$227.95 +0.2%		Overweight
AMAT Applied Materials	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shane Brett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$484.64 -0.1%	$642.00 ➝ $563.00	Equal Weight
APPF AppFolio	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$199.11 -2.5%	$240.00
ARE Alexandria Real Estate Equities	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.14 -3.6%	$52.00 ➝ $48.00	Market Perform
ASML ASML	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,782.88 +2.2%		Buy
ASTL Algoma Steel Group	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.35 +2.0%		Sector Perform
AUB Atlantic Union Bankshares	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Wilczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.67 -0.3%	$49.00 ➝ $50.00	Equal Weight
AUB Atlantic Union Bankshares	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Wilczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.67 -0.3%	$49.00 ➝ $50.00	Equal Weight
AVY Avery Dennison	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Dunigan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$172.13 +1.1%	$181.00	Hold
AYI Acuity	Downgraded by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Merkel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$306.51 -4.0%		Outperform ➝ Market Perform
AZO AutoZone	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Horvers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2,900.01 +1.0%	$3,850.00 ➝ $3,700.00	Overweight
BA Boeing	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sheila Kahyaoglu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.78 -6.2%		Buy ➝ Neutral
BAC Bank of America	Initiated by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$55.52 -2.1%	$65.00	Buy
BAK Braskem	Downgraded by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sriharsha Pappu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.54 -0.3%	$6.50 ➝ $1.50	Buy ➝ Hold
BKG The Berkeley Group	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 3,364 -0.2%	GBX 4,517 ➝ GBX 4,301	Buy
BL BlackLine	Downgraded by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucky Schreiner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.43 -5.6%	$30.00 ➝ $23.00	Neutral ➝ Underperform
BNTC Benitec Biopharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.78 +1.9%		Buy
BP BP	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.51 +0.8%		Buy
BP BP	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.51 +0.8%	$41.00 ➝ $47.00	Hold
BP BP	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 558.50 -2.3%		Buy
BROS Dutch Bros	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Curtis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.98 +0.2%	$85.00 ➝ $60.00	Buy
BTBT Bit Digital	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.72 -2.6%		Buy
BTRW Barratt Redrow	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 345.20 +11.7%	GBX 303 ➝ GBX 323	Hold
BUDA BUDA	Initiated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Kelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.78 +8.7%	$12.00	Buy
If you keep cash in a U.S. bank account… read this NOW (Ad) Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest. A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this fall, one that could offer savings rates up to 6 percent. See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live. Click here to see what Ian King found about this new savings shift
BWY Bellway	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,282 +10.3%	GBX 2,380	Buy
C Citigroup	Target Raised by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Domenico Santoro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$132.25 -1.5%	$161.00 ➝ $164.00	Buy
CAMT Camtek	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shane Brett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$141.73 -3.6%	$165.00 ➝ $152.00	Equal Weight
CARL Carlsmed	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.30 -5.3%	$23.00	Buy
CBSH Commerce Bancshares	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.88 -1.0%	$76.00 ➝ $77.00	Overweight
CF CF Industries	Upgraded by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mazahir Mammadli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$115.10 +0.4%	$98.00 ➝ $110.00	Sell ➝ Neutral
CFG Citizens Financial Group	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.91 -0.9%	$90.00 ➝ $89.00	Overweight
CFR Cullen/Frost Bankers	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$156.71 -0.5%	$200.00 ➝ $201.00	Overweight
CIZN Citizens	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.80 -2.5%		Market Outperform
CME CME Group	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Katz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$264.26 -0.1%	$292.00	Buy
COF Capital One Financial	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bill Carcache Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$197.25 -1.5%	$254.00 ➝ $260.00	Overweight
COIN Coinbase Global	Initiated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Glagola Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$193.68 -0.7%	$237.00	Outperform
COIN Coinbase Global	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$193.68 -0.7%	$130.00 ➝ $205.00	Neutral
COST Costco Wholesale	Reiterated by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Graja Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$921.55 -0.1%	$1,230.00	Buy
COST Costco Wholesale	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Krisztina Katai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$921.55 -0.1%	$1,091.00 ➝ $1,079.00	Buy
COST Costco Wholesale	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$921.55 -0.1%		Neutral
CPRT Copart	Reiterated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Bottiglieri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.20 -1.4%	$40.00 ➝ $43.00	Outperform
CRL Charles River Laboratories International	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Windley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$296.73 +1.3%	$305.00 ➝ $340.00	Buy
CRON Cronos Group	Reiterated by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.43 +2.6%		Buy
CRSP CRISPR Therapeutics	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yigal Nochomovitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.01 +1.4%		Market Outperform
CRST Crest Nicholson	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 65.50 +13.7%	GBX 107 ➝ GBX 80	Buy
CRWV CoreWeave	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Knoblauch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$86.29 -1.5%		Overweight
CTNM Contineum Therapeutics	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Hung Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.14 +4.6%	$18.00 ➝ $17.00	Equal Weight
CVX Chevron	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$206.16 +0.8%	$205.00 ➝ $215.00	Hold
CWEN Clearway Energy	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Souther Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.41 -1.2%	$43.00 ➝ $40.00	Buy
CWH Camping World	Reiterated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Stember Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.21 -3.4%	$12.00 ➝ $10.00	Buy
DAL Delta Air Lines	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Goldie Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.96 -1.2%	$105.00 ➝ $100.00	Outperform
DIDIY DiDi Global	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.59	$5.60	Buy
DIS Walt Disney	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$105.10 -1.0%		Buy
DIS Walt Disney	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Morris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$105.10 -1.0%	$120.00	Buy
DKNG DraftKings	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Hardiman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.29 -3.3%		Market Outperform
DTE DTE Energy	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Crowdell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$121.04 -0.3%	$152.00 ➝ $136.00	Outperform
DVN Devon Energy	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Margolin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.67 -0.8%	$65.00 ➝ $64.00	Overweight
EHC Encompass Health	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Cooper Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.75 +0.2%	$150.00
ENLT Enlight Renewable Energy	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Souther Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$68.84 -0.9%	$106.00 ➝ $104.00	Buy
EQNR Equinor ASA	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.32 +0.3%	$38.00 ➝ $41.00	Hold
EWBC East West Bancorp	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$127.12 -0.1%	$160.00 ➝ $164.00	Overweight
FIP FTAI Infrastructure	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.94 -6.2%	$9.00	Buy
FIP FTAI Infrastructure	Reiterated by	JonesTrading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Erdner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.94 -6.2%	$8.75	Buy
FISV Fiserv	Target Lowered by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hal Goetsch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.03 -1.0%	$66.00 ➝ $51.00	Neutral
FIVN Five9	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.95 -2.3%	$33.00
FLG Flagstar Bank, National Association	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.09 -2.3%	$17.00 ➝ $16.00	Overweight
FMCC Freddie Mac	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bose George Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.95 -5.0%	$6.50 ➝ $3.50	Underperform
FNMA Fannie Mae	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bose George Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.37 -6.4%	$6.25 ➝ $3.50	Underperform
FPLSF 5N Plus	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.70 +3.5%		Outperform
FRT Federal Realty Investment Trust	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$109.84 -0.6%	$123.00 ➝ $118.00	Equal Weight
FSLR First Solar	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Osha Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$172.89 -2.7%		Buy
FTV Fortive	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$55.55 -1.0%	$60.00	In-Line
FUL H. B. Fuller	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Zekauskas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.89 -0.3%	$67.00 ➝ $66.00	Overweight
FUL H. B. Fuller	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.89 -0.3%	$75.00 ➝ $63.00	Buy
A “bloodbath” Is Coming (Ad) Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the country entirely - as concerns grow about the next phase of the AI market. One AI insider says investors should reassess their positions before September 30, pointing to a critical shift ahead for tech and AI-related stocks. Read the full warning about the AI market's next phase now
GOOG Alphabet	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ross Sandler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$339.25 -0.5%	$395.00 ➝ $400.00	Overweight
GOOGL Alphabet	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Champion Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$342.54 -0.4%	$395.00 ➝ $400.00	Overweight
GPI Group 1 Automotive	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ward Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$241.98 -4.0%	$387.00 ➝ $357.00	Buy
GRAL GRAIL	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Mikson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.59 +3.7%	$80.00 ➝ $150.00	Buy
GS The Goldman Sachs Group	Target Raised by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Saul Martinez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$916.90 -2.0%	$995.00 ➝ $1,007.00	Hold
HUBG Hub Group	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Oglenski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.18 -0.5%	$48.00 ➝ $30.00	Equal Weight
HXL Hexcel	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sheila Kahyaoglu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.21 -1.9%	$110.00 ➝ $98.00	Hold
IBEX IBEX	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Koning Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$43.88 -1.5%	$40.00 ➝ $44.00	Neutral
ILMN Illumina	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Westenberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$270.63 +0.2%	$225.00 ➝ $305.00	Overweight
INCY Incyte	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashwani Verma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$124.57 +0.5%		Buy
INCY Incyte	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$124.57 +0.5%	$150.00 ➝ $152.00	Buy
INCY Incyte	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Fye Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$124.57 +0.5%	$120.00 ➝ $123.00	Neutral
IONQ IonQ	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.31 +1.8%	$60.00	Buy
IQV IQVIA	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jailendra Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$272.27 +0.7%	$300.00 ➝ $329.00	Buy
JBLU JetBlue Airways	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Goldie Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.28 -2.8%	$6.75 ➝ $5.25	Market Perform
JHX James Hardie Industries	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samuel Seow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.40 -2.7%		Buy ➝ Neutral
JPM JPMorgan Chase & Co.	Target Raised by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Domenico Santoro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$337.17 -1.7%	$369.00 ➝ $377.00	Hold
KDK Kodiak AI	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.38 -1.9%		Overweight
KGC Kinross Gold	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.24 -3.3%		Buy
KIM Kimco Realty	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.54 +0.4%	$28.00 ➝ $27.00	Overweight
KO CocaCola	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrea Teixeira Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$87.37 -0.5%	$96.00 ➝ $95.00	Overweight
KOD Kodiak Sciences	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Yee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.61 +183.2%	$80.00 ➝ $120.00	Buy
KOD Kodiak Sciences	Target Raised by	Lifesci Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Dolezal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.61 +183.2%	$85.00 ➝ $145.00	Outperform
KOD Kodiak Sciences	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.61 +183.2%	$58.00 ➝ $96.00	Buy
KRMN Karman	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Herbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.52 -6.1%	$85.00 ➝ $70.00	Outperform
KRSA Cyclerion Therapeutics	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yatin Suneja Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.46 -1.7%	$70.00	Buy
LAND Land Securities Group	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 619.50 +0.2%	GBX 462	Underperform
LBRT Liberty Energy	Upgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eddie Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.83 -0.6%	$27.00	Equal Weight ➝ Overweight
LEGN Legend Biotech	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.73 -2.0%		Buy
LEGN Legend Biotech	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashwani Verma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.73 -2.0%	$65.00	Buy
LFCR Lifecore Biomedical	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Max Smock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.55 +55.8%		Outperform ➝ Market Perform
LIN Linde	Target Lowered by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexandra Yates Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$473.88 +0.8%	$563.00 ➝ $538.00	Buy
LITE Lumentum	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Papa Sylla Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$904.37 -4.0%	$1,200.00 ➝ $1,400.00	Buy
LLY Eli Lilly and Company	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Schott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,188.47 +0.4%	$1,400.00 ➝ $1,500.00	Overweight
LMRI Lumexa Imaging	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Cooper Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.14 -0.7%	$17.00
LMRI Lumexa Imaging	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.14 -0.7%		Strong-Buy
LNSR LENSAR	Target Set by	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Nowak Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.89 -0.5%	$11.00
LSPD Lightspeed Commerce	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Baer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.76 -1.2%	$11.50 ➝ $9.50	Equal Weight
LUV Southwest Airlines	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Goldie Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.48 -0.5%	$60.00 ➝ $50.00	Outperform
LW Lamb Weston	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Pooran Sharma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.89 -1.6%	$55.00 ➝ $50.00	Equal Weight
LXRX Lexicon Pharmaceuticals	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Seedhouse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.93 +7.2%	$8.00	Overweight
MANH Manhattan Associates	Downgraded by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$201.41 -2.2%	$210.00	Buy ➝ Neutral
MANH Manhattan Associates	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$201.41 -2.2%	$210.00
MBGL Mobility Global	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Steinerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.70 -1.0%	$21.00	Neutral
MBX MBX Biosciences	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Yee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.61 +7.4%		Buy
MCD McDonald's	Target Lowered by	Melius Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jacob Aiken-Phillips Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$234.34 -0.9%	$250.00 ➝ $230.00	Sell
MCD McDonald's	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Harbour Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$234.34 -0.9%	$308.00 ➝ $297.00	Equal Weight
MDB MongoDB	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$342.49 -16.6%		Market Outperform
MDB MongoDB	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$342.49 -16.6%		Outperform
META Meta Platforms	Target Raised by	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian White Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$721.29 -4.0%	$730.00 ➝ $830.00	Buy
Trump goes "all-in" on Grand Canyon energy breakthrough (Ad) A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery. See the ticker behind this Grand Canyon energy breakthrough now
MIRM Mirum Pharmaceuticals	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.18 -1.7%	$140.00 ➝ $195.00	Buy
MMYT MakeMyTrip	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sachin Salgaonkar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.63 +1.9%	$71.00 ➝ $60.00	Buy
MNST Monster Beverage	Reiterated by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$41.83 -3.0%		Neutral
MRVL Marvell Technology	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Srini Pajjuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$252.11 -3.7%	$360.00	Outperform
MRVL Marvell Technology	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	C.J. Muse Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$252.11 -3.7%	$330.00	Neutral
MS Morgan Stanley	Target Raised by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dominic Ball Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$193.68 -1.3%	$215.00 ➝ $219.00	Hold
MSFT Microsoft	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$511.37 -0.9%		Buy
MTB M&T Bank	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$220.64 -0.2%	$304.00 ➝ $301.00	Overweight
MTZ MasTec	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dimple Gosai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$204.88 -3.7%	$321.00 ➝ $313.00	Neutral
MU Micron Technology	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tristan Gerra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,054.50 -2.6%	$1,280.00 ➝ $1,520.00	Outperform
MU Micron Technology	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Bryson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,054.50 -2.6%	$1,400.00	Outperform
NFLX Netflix	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laurent Yoon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.24 -2.7%		Buy
NHYDY Norsk Hydro ASA	Upgraded by	Danske Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.72 -0.2%		Sell ➝ Hold
NI NiSource	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Thalacker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.36 -0.2%	$49.00 ➝ $45.00	Outperform
NKE NIKE	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anna Andreeva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.49 +2.1%	$45.00 ➝ $38.00	Neutral
NKE NIKE	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Randal Konik Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.49 +2.1%		Buy
NKE NIKE	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Krisztina Katai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.49 +2.1%	$45.00 ➝ $37.00	Hold
NKE NIKE	Target Lowered by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Akshay Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.49 +2.1%	$48.00 ➝ $40.00	Hold
NKE NIKE	Target Lowered by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$36.49 +2.1%	$46.00 ➝ $34.00
NTES NetEase	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yang Liu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$121.14 +5.0%	$163.00	Overweight
NTNX Nutanix	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Calitri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$68.91 +1.3%	$85.00 ➝ $90.00	Buy
NU NU	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.34 -9.2%	$19.00	Buy
NU NU	Target Set by	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gonzalo López Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.34 -9.2%	$19.00
NVST Envista	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vik Chopra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.73 -0.9%	$29.00 ➝ $26.00	Market Perform
OKLO Oklo	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Souther Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.39 -1.7%	$51.00
OKTA Okta	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$202.64 +3.8%	$165.00 ➝ $190.00	Sector Outperform
OKTA Okta	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$202.64 +3.8%		Outperform
OKTA Okta	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rustam Kanga Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$202.64 +3.8%	$180.00 ➝ $225.00	Market Outperform
OMF OneMain	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$56.28 -1.9%	$71.00 ➝ $67.00	Buy
ONON ON	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashley Owens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.87 -0.3%		Overweight
ONON ON	Target Set by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashley Owens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.87 -0.3%	$37.00
OOMA Ooma	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.66 -0.5%		Market Perform
OZK Bank OZK	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.64 -0.5%	$56.00 ➝ $57.00	Underweight
PANW Palo Alto Networks	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gray Powell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$394.21 +5.2%	$404.00 ➝ $425.00	Buy
PAR PAR Technology	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.88 -1.3%	$25.00	Buy
PATH UiPath	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucky Schreiner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.23 -1.9%	$10.00	Neutral ➝ Underperform
PAYX Paychex	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Marcon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$99.91 -1.4%	$125.00 ➝ $110.00	Neutral
PAYX Paychex	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ramsey El-Assal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$99.91 -1.4%	$112.00 ➝ $96.00	Underweight
PB Prosperity Bancshares	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$67.35 -0.6%	$80.00 ➝ $81.00	Underweight
PCOR Procore Technologies	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.06 -0.5%	$56.00
PCOR Procore Technologies	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.06 -0.5%	$68.00	Overweight
PCVX Vaxcyte	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gerberry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.61 +4.3%	$133.00 ➝ $130.00	Buy
PEB Pebblebrook Hotel Trust	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	RJ Milligan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.78 +2.0%	$18.00 ➝ $20.00	Outperform
PECO Phillips Edison & Company, Inc.	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.58 +0.5%	$46.00 ➝ $43.00	Equal Weight
PEGA Pegasystems	Downgraded by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucky Schreiner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.09 -1.9%	$32.00	Buy ➝ Neutral
PEP PepsiCo	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Powers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$128.50 -0.1%	$155.00 ➝ $138.00	Buy ➝ Hold
PEP PepsiCo	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Powers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$128.50 -0.1%	$138.00	Buy ➝ Hold
PEP PepsiCo	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Moskow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$128.50 -0.1%	$145.00 ➝ $133.00	Hold
PFG Principal Financial Group	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Newsome Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$115.10 +0.3%	$125.00 ➝ $128.00	Overweight
PK Park Hotels & Resorts	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.78 +2.3%	$19.00	Market Perform ➝ Strong-Buy
"How Much Can I Actually Spend Each Year With $2.5M Saved?" (Ad) Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you make with it. Using the 4% rule as a benchmark, that balance could translate to about $100,000 in year one, adjusted upward for inflation each year after. But the 4% rule has potential downsides and may not fit every portfolio. A financial advisor can help size and structure a retirement budget around your income sources, taxes, and goals. SmartAsset's free quiz matches nearly 50,000 people each month with vetted fiduciary advisors. Take the free quiz to get matched with a fiduciary advisor
PK Park Hotels & Resorts	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.78 +2.3%		Neutral ➝ Hold
PK Park Hotels & Resorts	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Strong Buy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.78 +2.3%	$19.00	Market Perform ➝ Strong-Buy
PLTR Palantir Technologies	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$188.44 -0.6%		Neutral
PNC The PNC Financial Services Group	Target Raised by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Domenico Santoro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$223.98 -0.7%	$275.00 ➝ $283.00	Buy
PNFP Pinnacle Financial Partners	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Kenny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.15 -0.9%	$137.00 ➝ $139.00	Overweight
POR Portland General Electric	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregg Orrill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.25 -5.6%	$53.00 ➝ $50.00	Neutral
PPL PPL	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shahriar Pourreza Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$32.09 +0.2%	$43.00 ➝ $44.00	Overweight
PRME Prime Medicine	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.91 +0.2%		Market Outperform
PSN Parsons	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$41.48 -3.7%		Buy
PSN Persimmon	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,327 +14.9%	GBX 1,590	Buy
PSQL Pasqal	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.79 -2.9%	$16.00	Buy
PWR Quanta Services	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dimple Gosai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$644.64 -0.7%	$731.00 ➝ $714.00	Overweight
QTTB Q32 Bio	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Maury Raycroft Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.36 +6.8%	$29.00	Buy
RBLX Roblox	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Heaney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.66 -8.1%	$38.00	Hold ➝ Underperform
RCL Royal Caribbean Cruises	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Woronka Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$246.46 +1.5%	$299.00 ➝ $330.00	Hold ➝ Buy
RCL Royal Caribbean Cruises	Reiterated by	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$246.46 +1.5%	$425.00	Buy
RCL Royal Caribbean Cruises	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$246.46 +1.5%	$330.00	Neutral ➝ Buy
REG Regency Centers	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.44 +0.3%	$92.00 ➝ $85.00	Overweight
REXR Rexford Industrial Realty	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Kim Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.36 -0.3%	$38.00 ➝ $39.00	Outperform
REZI Resideo Technologies	Initiated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.35 +0.4%	$30.00	Outperform
RF Regions Financial	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Betsy Graseck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.34 -1.0%	$36.00 ➝ $35.00	Equal Weight
RGA Reinsurance Group of America	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$253.45 +1.9%	$295.00	Equal Weight ➝ Overweight
RGNX REGENXBIO	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.43 +0.3%		Buy
RH RH	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	W. Andrew Carter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.57 -0.5%	$130.00 ➝ $120.00	Hold
RHP Ryman Hospitality Properties	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	RJ Milligan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$122.22 +0.6%	$125.00 ➝ $130.00	Outperform
RIVN Rivian Automotive	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Sheppard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.93 -3.5%		Neutral
RLJ RLJ Lodging Trust	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	RJ Milligan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.10 -0.9%		Outperform ➝ Market Perform
ROC Rank One Computing	Initiated by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Van Sinderen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.39 +8.3%	$6.50	Buy
RPM RPM International	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vincent Sinisi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.19 -0.3%	$117.00 ➝ $114.00	Equal Weight
RSKD Riskified	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terry Tillman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.80 +0.2%	$7.50 ➝ $9.00	Buy
RVMD Revolution Medicines	Initiated by	Brookline Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leah Rush Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$204.52 -0.2%	$318.00	Buy
SAFE Safehold	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.11 -1.3%	$17.00 ➝ $13.00	Hold
SCHL Scholastic	Target Lowered by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Drew Crum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.26 +2.8%	$42.00 ➝ $35.00	Neutral
SEI Solaris Energy Infrastructure	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Anderson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.74 -1.7%	$90.00 ➝ $116.00	Overweight
SG Sweetgreen	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Trainor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.36 +1.4%	$6.00 ➝ $11.00	Equal Weight ➝ Overweight
SGMT Sagimet Biosciences	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.79 +6.0%	$29.00	Buy
SHEL Shell	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$96.65 +0.9%	$107.00 ➝ $115.00	Buy
SHW Sherwin-Williams	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John McNulty Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$332.69 +1.1%		Outperform
SIGI Selective Insurance Group	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Newsome Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.72 -1.6%	$105.00 ➝ $97.00	Neutral
SKT Tanger	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.82 +0.3%	$42.00 ➝ $41.00	Equal Weight
SPCX SpaceX	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Douglas Harned Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$147.39 -0.9%		Outperform ➝ Buy
SPCX SpaceX	Initiated by	CLSA Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$147.39 -0.9%	$250.00	Outperform
SPCX SpaceX	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edison Yu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$147.39 -0.9%	$235.00	Buy
SPG Simon Property Group	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$204.31 -0.2%	$215.00 ➝ $208.00	Equal Weight
SPHR Sphere Entertainment	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler DiMatteo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.00 -0.8%		Buy
SRC SigmaRoc	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 128.50 +2.2%	GBX 130	Hold
SRPT Sarepta Therapeutics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Blum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.71 +0.2%		Underperform
STZ Constellation Brands	Target Lowered by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nadine Sarwat Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.66 -0.9%	$197.00 ➝ $180.00	Outperform
T AT&T	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simon Flannery Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.96 -1.7%	$27.00 ➝ $28.00	Overweight
TDG Transdigm Group	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Goldie Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,105.00 -1.0%	$1,525.00 ➝ $1,400.00	Outperform
TEAM Atlassian	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$178.34 -5.0%	$200.00 ➝ $245.00	Outperform
TFC Truist Financial	Initiated by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$47.21 -1.0%	$61.00	Buy
TFX Teleflex	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Bijou Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$127.96 +4.8%	$145.00 ➝ $158.00	Neutral ➝ Buy
TMUS T-Mobile US	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$166.95 +0.9%		Neutral
TPK Travis Perkins	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 620 +3.6%	GBX 443 ➝ GBX 453	Underperform
TROW T. Rowe Price Group	Target Raised by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Glenn Schorr Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.55 -1.9%	$113.00 ➝ $121.00
TRT Trio-Tech International	Initiated by	D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick McCann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.47 +4.0%	$17.00	Buy
TSLA Tesla	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rajat Gupta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$359.15 -3.5%	$445.00 ➝ $415.00	Neutral
TSLA Tesla	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Sheppard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$359.15 -3.5%		Overweight
TTWO Take-Two Interactive Software	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$201.48 +0.0%	$310.00
TW Taylor Wimpey	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 80.10 +1.6%	GBX 101	Buy
TXG 10x Genomics	Initiated by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Eade Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.57 +3.3%	$110.00	Buy
TXG 10x Genomics	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Westenberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.57 +3.3%	$47.00 ➝ $80.00	Neutral
TYL Tyler Technologies	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clarke Jeffries Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$322.45 -1.0%	$491.00 ➝ $450.00	Overweight
UAL United Airlines	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Goldie Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.06 -1.7%	$157.50 ➝ $140.00	Outperform
UMBF UMB Financial	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Wilczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$134.07 -1.3%	$190.00 ➝ $182.00	Overweight
USB U.S. Bancorp	Target Raised by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Domenico Santoro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.85 -0.8%	$74.00 ➝ $76.00	Buy
VIK Viking	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Wieczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.51 -1.0%	$120.00 ➝ $115.00	Buy
VLY Valley National Bancorp	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.85 -1.8%	$17.00 ➝ $16.00	Equal Weight
VRT Vertiv	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Varun Govindaraj Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$244.84 -3.3%		Outperform
VRTX Vertex Pharmaceuticals	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Yee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$527.50 +0.2%	$585.00 ➝ $615.00	Buy
VSTM Verastem	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.64 -1.4%		Overweight
VTY Vistry Group	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 286.60 +11.4%	GBX 263 ➝ GBX 252	Hold
WBI WBI	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Goldfarb Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.15 -2.2%	$37.00	Overweight
WFC Wells Fargo & Company	Initiated by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$81.07 -2.3%	$108.00	Buy
WPP WPP	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 385.80 -2.0%	GBX 470	Buy
XENE Xenon Pharmaceuticals	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Tsai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.62 -0.9%	$90.00	Buy
XNCR Xencor	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Renza Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.54 +7.3%	$27.00 ➝ $29.00	Buy
XOM ExxonMobil	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Gabelman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$162.06 +0.9%	$168.00 ➝ $180.00	Buy
YETI YETI	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian McNamara Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$43.54 +3.0%	$45.00 ➝ $46.00	Hold
ZBH Zimmer Biomet	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vik Chopra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.27 +0.3%		Market Perform
ZI ZoomInfo Technologies	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.75 -4.3%	$4.25
ZION Zions Bancorporation, N.A.	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$63.21 -1.0%	$77.00 ➝ $78.00	Underweight
ZS Zscaler	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Wahrhaftig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$201.33 +4.3%	$215.00	Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 02:52 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings